Quantum acquires NeuWave Medical to enhance tumor ablation remedies
Quantum Surgical has acquired NeuWave Medical, supporting its technique to broaden entry to robotic-assisted tumor ablation remedies to cut back most cancers mortality.
This transfer brings collectively two medical machine corporations with a shared deal with innovation for most cancers affected person outcomes.
Uncover B2B advertising and marketing that delivers
Mix enterprise intelligence and editorial excellence to succeed in engaged professionals throughout 36 main media platforms.
Extra info
Each corporations will now function as subsidiaries underneath Precision IO Group, a brand new guardian firm led by CEO Kurt Azarbarzin.
Quantum Surgical has developed the Epione robotic platform for early stage tumor interventions. This enables medical doctors to carry out percutaneous tumor ablations, through which a number of needles are inserted by way of the pores and skin to deal with tumors.
NeuWave Medical supplies microwave ablation expertise for percutaneous procedures and experiences use in 70% of US most cancers facilities.
Quantum Surgical president and co-founder Bertin Nahum stated, “At Quantum Surgical, we’re dedicated to democratizing procedural data by way of robotics and increasing high-quality most cancers look after sufferers. The acquisition of NeuWave Medical is a pure and strategic step in that mission.
“Innovation is our north star, and we’re excited to hitch forces with a passionate crew of consultants to additional drive innovation and form the way forward for interventional oncology.”
NeuWave Medical President Leah Kissling stated, “We’re proud to hitch the Quantum Surgical crew and proceed to assist physicians of their mission to deal with most cancers sufferers. We stay up for combining our capabilities with Quantum Surgical to drive innovation and assist remodel the way forward for most cancers care.”
Precision IO Group develops distant intervention tasks utilizing Epione instruments, which allow international skilled enter for trajectory planning and consequence evaluation.
Distant interventions will allow larger entry to specialty care with out journey, enabling real-time international collaboration amongst physicians for exact, minimally invasive procedures.
Epione obtained CE Mark approval for thoracic, stomach and musculoskeletal indications, together with approval from the US Meals and Drug Administration (FDA) for stomach ablation. Greater than 1,400 sufferers have been handled with the expertise within the US and Europe.
